Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube
 

Journal of Cancer Science & Therapy


Open Access
 
 
 
ISSN: 1948-5956
 
 
 
HOME » CANCER-SCIENCE-THERAPY
French Language  |  English
 
 
 
 
SCImago Journal & Country Rank
 
 
 

Upcoming Event

 

Upcoming Special Issues

Special issue entitled: "Cancer Research: Clinical & Experimental" has been edited by
 
 

Jimmy Thomas Efird, PhD
Center for Health of Vulnerable Populations
University of North Carolina
Greensboro
USA
Tel. 650-248-8282
E-mail: jimmy.efird@stanfordalumni.org

 
Special issue entitled: "Cancer Chemoprevention" has been edited by
 
 

Rajendra Sharma, PhD
Associate Professor
Molecular Biology and Immunology
University of North Texas
USA
Tel. 817 735 2140
Fax 817 735 2118
E-mail: sharmarajendra@hotmail.com

 
Read More»
 

About the Journal

Editor-in-Chief
Sudhakar Akul Yakkanti, PhD
Professor
USA
 
Impact Factor: 4.203*
H-Factor: 7
Index Copernicus Value: 5.13

flyer image

ISSN: 1948-5956
NLM ID: 101526958

 

Cancer is a pathological condition, where assemblage of cells displays uncontrolled growth, invasion and sometimes metastasis. Starting from diagnosis, therapy, and post therapy procedures, cancer treatment involves various Medical, Clinical, Pathological, Psychological approaches with several implications. Cancer research and Tumors science hence is an ever growing literature with the advancement of new therapeutic solutions to prevent, handle and fight it effectively.
 
Information plays a pivotal role at every stage of the cancer treatment and prevention. The Journal of Cancer Research and therapy (JCST) is a peer reviewed journal that offers a platform that accommodates a wide range of fields in its discipline for the authors to make their contribution towards the journal where the editorial office promises a quick and value added review process for the submitted manuscripts for the quality of publishing.
 
JCST is an Open Access publishing journal that aims to publish most complete and reliable source of information on the discoveries and current developments in the form of original articles, review articles, case reports, short communications, etc. related to Cancer research and therapy and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
 
This top best open access journal is using Editorial Manager® System for quality in review process. Editorial Manager® is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of the JCST or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
 
OMICS Group International is a leading Open Access publisher that publishes more than 500+ peer-reviewed Open Access Journals and organizes over 300+ International Conferences globally with the support of nearly 1000 International Societies. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.
 
Journal of Cancer Science and Therapy is supporting 5th World congress on Cancer Therapy which is going to be held during September 28-30, 2015, at Atlanta, USA. The theme of the conference is “Emerging Therapeutic advances in cancer therapy”.
 
Submit manuscript at http://www.editorialmanager.com/cancerscience/ or send as an e-mail attachment to the Editorial Office at editor.jcst@omicsonline.org or editor.jcst@omicsgroup.biz
 
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = Y/X

 

 

Recently published articles

Nurses’ Attitude, Practice and Barriers toward Cancer Pain Management, Addis Ababa, Ethiopia

Rahel Nega Kassa and Getachew Mullu Kassa

 
Targetting Cdks in Cancer: An Overview and New Insights

Gousia Chashoo and Ajit Kumar Saxena

 
Resveratrol Modulates Expression of ABC Transporters in Non-Small Lung Cancer Cells: Molecular Docking and Gene Expression Studies

Subburayan Karthikeyan, Sugeerappa Laxmanappa Hoti and Nagarajan Rajendra Prasad

 
Psammaplin A: A Putative Adjuvant for DNA Damaging Therapies

Jamile Charkie

 
Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment

Chandi C Mandal and Md Mizanur Rahman 

 
 
 
 
 
Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country USA
USA  USA Spain  Spain
Australia  Australia Canada Canada
UAE  UAE China China
Italy  Italy France France
Germany  Germany India India
UK  UK Malaysia Malaysia
Japan  Japan singapore Singapore
France  Brazil South Africa South Africa
South Korea South Korea
 
Conferences By City USA
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
 
Conferences By Subject USA
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
 
 
© 2008–2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version